Literature DB >> 25633788

Obesity and diabetes: FXR and JAK step up to BAT.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25633788     DOI： 10.1038/nrd4543

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance.

Authors:  Sungsoon Fang; Jae Myoung Suh; Shannon M Reilly; Elizabeth Yu; Olivia Osborn; Denise Lackey; Eiji Yoshihara; Alessia Perino; Sandra Jacinto; Yelizaveta Lukasheva; Annette R Atkins; Alexander Khvat; Bernd Schnabl; Ruth T Yu; David A Brenner; Sally Coulter; Christopher Liddle; Kristina Schoonjans; Jerrold M Olefsky; Alan R Saltiel; Michael Downes; Ronald M Evans
Journal:  Nat Med       Date:  2015-01-05       Impact factor: 53.440

2.  White-to-brown metabolic conversion of human adipocytes by JAK inhibition.

Authors:  Annie Moisan; Youn-Kyoung Lee; Jitao David Zhang; Carolyn S Hudak; Claas A Meyer; Michael Prummer; Sannah Zoffmann; Hoa Hue Truong; Martin Ebeling; Anna Kiialainen; Régine Gérard; Fang Xia; Robert T Schinzel; Kurt E Amrein; Chad A Cowan
Journal:  Nat Cell Biol       Date:  2014-12-08       Impact factor: 28.824
  2 in total
  2 in total

1.  Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.

Authors:  Haiping Hao; Lijuan Cao; Changtao Jiang; Yuan Che; Songyang Zhang; Shogo Takahashi; Guangji Wang; Frank J Gonzalez
Journal:  Cell Metab       Date:  2017-04-04       Impact factor: 27.287

2.  Bile acid signaling and bariatric surgery.

Authors:  Jingyan Tian; Silvia Huang; Siming Sun; Lili Ding; Eryun Zhang; Wendong Huang
Journal:  Liver Res       Date:  2017-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.